2023 Form 5500 filing — Zymeworks Biopharmaceuticals 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240503142847NAL0029872577001) for Zymeworks Biopharmaceuticals 401(K) Plan, reported by Zymeworks Biopharmaceuticals Inc. under EIN 47-2569713 and plan number 001. It reports 225 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240503142847NAL0029872577001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Zymeworks Biopharmaceuticals Inc.
- EIN
- 47-2569713
- Plan number
- 001
- Location
- not reported in the loaded dataset
- Participants
- 225
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $11,966,451
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $11,966,451
- Employer contributions
- $1,182,268
- Participant contributions
- $1,644,036
- Total income / additions
- $5,339,466
- Benefits paid
- $4,340,540
- Administrative expenses
- $158,118
- Total expenses
- $4,498,658
- Net increase / (decrease)
- $840,808
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Empower Annuity Ins. Co. Of America | RECORDKEEPER | $109,016 | not reported in the loaded dataset |
| Morgan Stanley Smith Barney LLC | BROKER/ADVISER | $0 | $48,211 |
| Definiti LLC | CONTRACT ADMIN | $7,812 | $10,000 |
| Leafhouse Financial Advisors, LLC | OTHER | $5,171 | not reported in the loaded dataset |
| Morgan Stanley Insurance Services I | BROKER/ADVISER | $0 | $582 |